Schizophrenia Study In Adults
NCT00049946 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 231
Last updated 2017-08-16
Summary
A Placebo Controlled Study For Patients With Schizophrenia
Conditions
Interventions
- DRUG
-
talnetant
- DRUG
-
risperidone
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials, MD · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-10-31
- Primary Completion
- 2003-04-30
- Completion
- 2003-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone
NCT02019329 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
NCT00034749 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia
NCT00249132 ·Status: COMPLETED ·Phase: PHASE3
-
Risperidone Augmentation in Patients With Schizophrenia
NCT00289861 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Seroquel in First Episode Schizophrenia
NCT00254241 ·Status: COMPLETED ·Phase: PHASE4
-
Study of a Novel Antipsychotic ITI-007 in Schizophrenia
NCT01499563 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia
NCT00589914 ·Status: COMPLETED ·Phase: PHASE3
-
An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)
NCT03055338 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia
NCT00249119 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Paliperidone Palmitate in Participants With Schizophrenia
NCT01299389 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
NCT00249223 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients
NCT00921804 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment
NCT02469155 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone
NCT00535132 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Schizophrenia Patients
NCT01086748 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia
NCT01051531 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol
NCT00253162 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020
NCT00722176 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.
NCT00250367 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of MP-214 in Patients With Schizophrenia
NCT01625000 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone
NCT00246272 ·Status: COMPLETED ·Phase: PHASE3
-
Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI
NCT01234454 ·Status: COMPLETED ·Phase: NA
-
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
NCT00249236 ·Status: COMPLETED ·Phase: PHASE3
-
Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder
NCT00158028 ·Status: COMPLETED ·Phase: NA
-
A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder
NCT00253149 ·Status: COMPLETED ·Phase: PHASE3